1. A pooled safety analysis of peficitinib (ASP015K) in Asian patients with rheumatoid arthritis treated over a median of 2 years. Issue 3 (4th May 2021) Authors: Takeuchi, Tsutomu; Tanaka, Yoshiya; Rokuda, Mitsuhiro; Izutsu, Hiroyuki; Kaneko, Yuichiro; Fukuda, Musashi; Kato, Daisuke Journal: Modern rheumatology Issue: Volume 31:Issue 3(2021) Page Start: 543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium–glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase‐4 inhibitor: A real‐world administrative database study in Japan. Issue 3 (14th December 2022) Authors: Kashiwagi, Atsunori; Shoji, Shingo; Kosakai, Yoshinori; Koga, Tadashi; Asakawa, Keiko; Rokuda, Mitsuhiro Journal: Journal of diabetes investigation Issue: Volume 14:Issue 3(2023) Page Start: 404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Demographic and clinical characteristics of patients with type 1 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors in Japan: A real-world administrative database analysis. (August 2022) Authors: Abiru, Norio; Shoji, Shingo; Kosakai, Yoshinori; Snijder, Robert; Asakawa, Keiko; Rokuda, Mitsuhiro Journal: Diabetes research and clinical practice Issue: Volume 190(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3). Issue 10 (26th July 2019) Authors: Tanaka, Yoshiya; Takeuchi, Tsutomu; Tanaka, Sakae; Kawakami, Atsushi; Iwasaki, Manabu; Song, Yeong Wook; Chen, Yi-Hsing; Wei, James Cheng-Chung; Lee, Sang-Heon; Rokuda, Mitsuhiro; Izutsu, Hiroyuki; Ushijima, Satoshi; Kaneko, Yuichiro; Akazawa, Rio; Shiomi, Teruaki; Yamada, Emi Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 10(2019) Page Start: 1320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan. Issue 10 (October 2019) Authors: Takeuchi, Tsutomu; Tanaka, Yoshiya; Tanaka, Sakae; Kawakami, Atsushi; Iwasaki, Manabu; Katayama, Kou; Rokuda, Mitsuhiro; Izutsu, Hiroyuki; Ushijima, Satoshi; Kaneko, Yuichiro; Shiomi, Teruaki; Yamada, Emi; van der Heijde, Désirée Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 10(2019) Page Start: 1305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan. Issue 10 (26th July 2019) Authors: Takeuchi, Tsutomu; Tanaka, Yoshiya; Tanaka, Sakae; Kawakami, Atsushi; Iwasaki, Manabu; Katayama, Kou; Rokuda, Mitsuhiro; Izutsu, Hiroyuki; Ushijima, Satoshi; Kaneko, Yuichiro; Shiomi, Teruaki; Yamada, Emi; van der Heijde, Désirée Journal: Annals of the rheumatic diseases Issue: Volume 78:Issue 10(2019) Page Start: 1305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0134 A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PEFICITINIB (ASP015K) IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAD AN INADEQUATE RESPONSE TO DMARDS. (June 2019) Authors: Tanaka, Yoshiya; Takeuchi, Tsutomu; Tanaka, Sakae; Kawakami, Atsushi; Iwasaki, Manabu; Song, Yeong Wook; Chen, Yi-Hsing; Rokuda, Mitsuhiro; Izutsu, Hiroyuki; Ushijima, Satoshi; Kaneko, Yuichiro; Shiomi, Teruaki; Yamada, Emi Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0165 PATIENT- AND PHYSICIAN-REPORTED OUTCOMES FROM RAJ4: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF PEFICITINIB (ASP015K) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) WHO HAD AN INADEQUATE RESPONSE TO METHOTREXATE (MTX). (June 2019) Authors: Tanaka, Yoshiya; Takeuchi, Tsutomu; Rokuda, Mitsuhiro; Izutsu, Hiroyuki; Kaneko, Yuichiro; Shiomi, Teruaki; Yamada, Emi Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP0026 A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PEFICITINIB (ASP015K) IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAD AN INADEQUATE RESPONSE TO METHOTREXATE. (June 2019) Authors: Takeuchi, Tsutomu; Tanaka, Yoshiya; Tanaka, Sakae; Kawakami, Atsushi; Iwasaki, Manabu; Rokuda, Mitsuhiro; Izutsu, Hiroyuki; Ushijima, Satoshi; Kaneko, Yuichiro; Shiomi, Teruaki; Yamada, Emi Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗